Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2021 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.
Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332.
Cancers (Basel). 2021.
PMID: 34503142
Free PMC article.
Review.
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A, Ramos-Campoy S, Kamaso J, de la Rosa M, Salido M, Melero C, Rodríguez-Rivera M, Bougeon S, Collado R, Gimeno E, García-Serra R, Alonso S, Moro-García MA, García-Malo MD, Calvo X, Arenillas L, Ferrer A, Mantere T, Hoischen A, Schoumans J, Espinet B.
Puiggros A, et al. Among authors: garcia malo md.
Cancers (Basel). 2022 Jul 11;14(14):3376. doi: 10.3390/cancers14143376.
Cancers (Basel). 2022.
PMID: 35884436
Free PMC article.
Item in Clipboard
NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition.
Carrillo-Tornel S, Chen-Liang TH, Zurdo M, Puiggros A, Gómez-Llonín A, García-Malo MD, Cuenca-Zamora EJ, Ortuño FJ, López AMH, Espinet B, Jerez A.
Carrillo-Tornel S, et al. Among authors: garcia malo md.
Br J Haematol. 2023 May;201(3):470-479. doi: 10.1111/bjh.18609. Epub 2022 Dec 27.
Br J Haematol. 2023.
PMID: 36573331
Item in Clipboard
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
de la Asunción CS, Giménez E, Hernández-Boluda JC, Terol MJ, Albert E, López J, García-Gutiérrez V, Andreu R, Malo MDG, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D.
de la Asunción CS, et al. Among authors: malo mdg.
J Med Virol. 2023 Jul;95(7):e28933. doi: 10.1002/jmv.28933.
J Med Virol. 2023.
PMID: 37403897
Item in Clipboard
Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance.
Baptista MJ, Granada I, Morgades M, Calasanz MJ, Canals J, Robles De Castro D, Luño E, Ruiz-Xivillé N, Rodríguez-Hernández I, González T, Terol MJ, Valiente A, Ortuño F, Garcia-Malo MD, Piñan MÁ, Oliveira AC, Talavera M, Buño I, Batlle-López A, Moreno C, Ferra C, Solé F.
Baptista MJ, et al. Among authors: garcia malo md.
Am J Hematol. 2017 Jul;92(7):E132-E135. doi: 10.1002/ajh.24754. Epub 2017 Jun 1.
Am J Hematol. 2017.
PMID: 28383114
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Abrisqueta P, Loscertales J, Terol MJ, Ramírez Payer Á, Ortiz M, Pérez I, Cuellar-García C, Fernández de la Mata M, Rodríguez A, Lario A, Delgado J, Godoy A, Arguiñano Pérez JM, Berruezo MJ, Oliveira A, Hernández-Rivas JÁ, García Malo MD, Medina Á, García Martin P, Osorio S, Baltasar P, Fernández-Zarzoso M, Marco F, Vidal Manceñido MJ, Smucler Simonovich A, López Rubio M, Jarque I, Suarez A, Fernández Álvarez R, Lancharro Anchel A, Ríos E, Losada Castillo MDC, Pérez Persona E, García Muñoz R, Ramos R, Yáñez L, Bello JL, Loriente C, Acha D, Villanueva M.
Abrisqueta P, et al. Among authors: garcia malo md.
Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e985-e999. doi: 10.1016/j.clml.2021.07.022. Epub 2021 Aug 3.
Clin Lymphoma Myeloma Leuk. 2021.
PMID: 34511320
Free article.
Item in Clipboard
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group.
García-Marco JA, et al. Among authors: malo mdg.
Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19.
Haematologica. 2019.
PMID: 30890600
Free PMC article.
Item in Clipboard
Cite
Cite